BWXT

BWX Technologies, Inc. (BWXT) - Q2 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2026. BWX Technologies, Inc. operates in two primary segments: Government Operations (naval nuclear reactors, fuel, and services for the U.S. Government) and Commercial Operations (nuclear components, fuel, and services for global utilities and medical isotopes). The company is a large accelerated filer with 91.6 million shares of common stock outstanding as of July 31, 2026.

Key Financial Metrics (Six Months Ended June 30, 2026)

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenue increased by $315.5 million (21.8%) year-over-year. This was driven primarily by the Commercial Operations segment, which saw a 92.5% increase ($281.7 million) largely due to the full-year impact of the Kinectrics acquisition (completed May 2025) and higher demand for nuclear services and fuel handling.
• Segment Performance:
  • Government Operations: Revenue increased 3.1% to $1.18 billion, driven by enrichment operations and the Aerojet Ordnance Tennessee (A.O.T.) acquisition. Operating income decreased slightly ($2.3 million) due to favorable contract adjustments in the prior year that did not recur.
  • Commercial Operations: Operating income surged $35.0 million to $48.4 million, with margins improving from 4.4% to 8.3% due to revenue growth and a favorable product mix shift.
• Corporate Expenses: Unallocated corporate expenses increased by $10.9 million year-over-year, primarily due to legal and consulting costs related to M&A activities and higher healthcare costs.
• Tax Rate: The effective tax rate for the six months was 18.4%, lower than the 21% statutory rate, due to R&D tax credits and equity compensation benefits.

Guidance, Outlook, and Material Events

• Acquisitions:
  • Precision Components Group (PCG): Completed on July 1, 2026. This acquisition expands heavy-manufacturing capacity for commercial nuclear production. A preliminary purchase price allocation has not yet been completed.
  • Kinectrics & A.O.T.: Full integration continues, driving significant commercial revenue growth.
• Divestiture: On July 31, 2026, BWXT entered a definitive agreement to sell its medical business (including BWXT Medical and Kinectrics' stable medical isotope business) to Nordic Capital for up to $800 million. BWXT will retain a minority interest. Closing is expected in late 2026 or Q1 2027.
• Liquidity & Capital Structure:
  • In November 2025, the company established a new $1.25 billion senior secured revolving credit facility maturing in 2030. As of June 30, 2026, there were no outstanding borrowings, with $1.25 billion available.
  • The company issued $1.25 billion of 0% Convertible Senior Notes due 2030 in November 2025, which were used to repay prior term loans.
• Backlog: Total backlog stands at $8.398 billion, with $2.256 billion in unfunded U.S. Government contracts. Approximately 55% of backlog revenue is expected to be recognized by the end of 2027.
• Risks: Key risks include U.S. Government budget uncertainty, potential program cancellations, and the timing of commercial nuclear refueling outages. The company notes that forward-looking statements are subject to these uncertainties.

Investor Verification Checklist

• Medical Business Sale: Verify the final transaction value and closing date of the Nordic Capital deal, and confirm the retained minority interest structure.
• PCG Acquisition: Monitor the upcoming purchase price allocation for the Precision Components Group acquisition to understand goodwill and intangible asset impacts.
• Convertible Notes: Review the terms of the $1.25 billion 0% Convertible Senior Notes due 2030, specifically the conversion price ($262.51) and the capped call transactions used to mitigate dilution.
• Government Funding: Assess the impact of the U.S. Government's fiscal year budget cycle on the $2.256 billion of unfunded backlog in the Government Operations segment.
• Margin Sustainability: Evaluate whether the 8.3% operating margin in Commercial Operations is sustainable as the one-time benefits from the Kinectrics acquisition normalize.